Purchases and Sales Made in Q2 2024 in Kal Vista Pharmaceuticals, Inc. (KALV)
This table provides information about the institutional ownership of Kal Vista Pharmaceuticals, Inc. (KALV) during Q2 2024. The information is specifically focused on institutions that hold shares of KalVista Pharmaceuticals, Inc..
Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
---|---|---|---|---|---|---|---|
Aug 14, 2024
Q2 2024
|
Marshall Wace, LLP
London, X0 |
SELL
|
- |
-580K- 92.22% |
$6M - $7.24M
|
48.9K
$779K
|